June 7, 2022
10:00-11:00 AM EST
Large corporations can use Corporate Venture Capital (CVC) as a vehicle to get early access to new innovations. They strategically look for companies developing assets and technologies that might complement their pipeline in the future.
So, how do CVCs maximize the value for their company with a balance between capital and strategic objectives? Join us on 7 June to find out!
More speakers to be announced soon
16:00 CEST Introduction by Johnson & Johnson Innovation
16:05 CEST Fund structures and the relevance of Equity Investing
16:15 CEST Panel discussion
Lucio Iannone | Vice President Venture Investments, Leaps by Bayer
Fiona MacLaughlin | Principal, Venture Investment, Johnson & Johnson Innovation – JJDC
Barbara Dalton | Senior Managing Partner, Pfizer Ventures*
Ezra Miller | moderator*
16:45 CEST Audience Q&A
17:00 CEST Event Close
* final confirmation pending